Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 14 studies | 52% ± 22% | |
endothelial cell | 3 studies | 27% ± 6% | |
kidney loop of Henle epithelial cell | 3 studies | 29% ± 8% |
Insufficient scRNA-seq data for expression of RANBP3L at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 96% | 680.94 | 235 / 245 | 99% | 18.86 | 497 / 502 |
brain | 87% | 1482.89 | 2310 / 2642 | 98% | 29.53 | 688 / 705 |
breast | 59% | 332.11 | 273 / 459 | 54% | 4.99 | 609 / 1118 |
kidney | 93% | 859.69 | 83 / 89 | 15% | 1.69 | 135 / 901 |
thymus | 86% | 275.91 | 564 / 653 | 21% | 1.03 | 129 / 605 |
blood vessel | 95% | 869.62 | 1270 / 1335 | 0% | 0 | 0 / 0 |
bladder | 76% | 832.90 | 16 / 21 | 7% | 0.42 | 36 / 504 |
lung | 74% | 253.88 | 425 / 578 | 9% | 0.38 | 106 / 1155 |
liver | 62% | 209.25 | 139 / 226 | 16% | 1.04 | 66 / 406 |
adrenal gland | 41% | 112.08 | 105 / 258 | 18% | 1.74 | 41 / 230 |
adipose | 53% | 166.96 | 633 / 1204 | 0% | 0 | 0 / 0 |
ovary | 35% | 94.62 | 63 / 180 | 11% | 0.58 | 48 / 430 |
uterus | 35% | 91.29 | 60 / 170 | 10% | 0.81 | 45 / 459 |
stomach | 42% | 99.70 | 151 / 359 | 2% | 0.10 | 7 / 286 |
esophagus | 34% | 111.23 | 497 / 1445 | 4% | 0.19 | 7 / 183 |
intestine | 19% | 45.30 | 185 / 966 | 2% | 0.05 | 8 / 527 |
heart | 20% | 48.24 | 174 / 861 | 0% | 0 | 0 / 0 |
skin | 17% | 53.03 | 312 / 1809 | 2% | 0.11 | 8 / 472 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.23 | 3 / 45 |
pancreas | 0% | 0 | 0 / 328 | 4% | 0.17 | 8 / 178 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.17 | 1 / 29 |
muscle | 2% | 5.26 | 19 / 803 | 0% | 0 | 0 / 0 |
spleen | 0% | 0.51 | 1 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1901706 | Biological process | mesenchymal cell differentiation involved in bone development |
GO_0045663 | Biological process | positive regulation of myoblast differentiation |
GO_0006611 | Biological process | protein export from nucleus |
GO_0045668 | Biological process | negative regulation of osteoblast differentiation |
GO_0005737 | Cellular component | cytoplasm |
GO_0005643 | Cellular component | nuclear pore |
GO_0046332 | Molecular function | SMAD binding |
GO_0005515 | Molecular function | protein binding |
GO_0005096 | Molecular function | GTPase activator activity |
Gene name | RANBP3L |
Protein name | RAN binding protein 3 like Ran-binding protein 3-like |
Synonyms | |
Description | FUNCTION: Nuclear export factor for BMP-specific SMAD1/5/8 that plays a critical role in terminating BMP signaling and regulating mesenchymal stem cell differentiation by blocking osteoblast differentiation to promote myogenic differention. Directly recognizes dephosphorylated SMAD1/5/8 and mediates their nuclear export in a Ran-dependent manner. . |
Accessions | ENST00000515759.5 [Q86VV4-2] ENST00000505865.1 Q86VV4 D6RCM9 ENST00000296604.8 [Q86VV4-1] ENST00000502994.5 [Q86VV4-3] |